The proposal requests support for prospective continuation of a population-based cross-sectional study of insulin secretory reserve and glucose tolerance among the adults of Wadena, MN. The target subjects include 60 previously-diagnosed diabetic individuals, and 400 members of a random sample of adults without previously-known diabetes, chosen from a 99%-complete census of adult residents, stratified for age, gender, and use or non-use of chronic medication. C-peptide in a 4-hour timed urine collection, and plasma C-peptide, will be measured following a 75 gm oral glucose load, as part of a glucose tolerance test (National Diabetes Data Group methodology); these tests will be performed 3 and 6 years after the initial cross-section study. The study will test these central hypotheses: 1) most non-insulin-dependent diabetic (NIDDM) subjects show generous insulin production, sustained overtime; 2) older non-diabetic subjects show no systematic decline in insulin production; 3) a small subset of NIDDM subjects, identiable by immunologic tests, are at risk for declining insulin production and represent a different disorder; 4) risk for vascular complications (eye, kidney, heart) is related to degree of hyperglycemia rather than type of diabetes. The results should have value in guiding future studies of the nature of the common form of diabetes and in eventual development of more rational treatments than is currently available. The study is a cooperative project among treatment than is currently available. The study is a cooperative project among the schools of Medicine and Public Health, University of Minnesota, Minnesota Department of Health, and the Wadena Medical Center and Tri- county Hospital.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
Schools of Medicine
United States
Zip Code
Goetz, Frederick C; Roel, Joseph; Jacobs Jr, David R et al. (2002) Declining beta-cell function in type 2 diabetes: 5-year follow-up and immunologic studies of the population of Wadena, MN. Metabolism 51:144-8
Adachi, H; Goetz, F C; Jacobs, D R et al. (2000) The role of obesity in the association of cardiovascular risk factors and glucose intolerance in small Japanese and North American communities. Diabetes Res Clin Pract 49:41-51
Goetz, F C; Jacobs Jr, D R; Chavers, B et al. (1997) Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol 145:91-102
McEvoy, R C; Thomas, N M; Greig, F et al. (1996) Anti-islet autoantibodies detected by monoclonal antibody 1A2: further studies suggesting a role in the pathogenesis of IDDM. Diabetologia 39:1365-71
Goetz, F C; French, L R; Thomas, W et al. (1995) Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota. Metabolism 44:1371-6
Clements, J P; French, L R; Boen, J R et al. (1994) A reassessment of fasting plasma glucose concentrations in population screening for diabetes mellitus in a community of northern European ancestry: the Wadena City Health Study. Acta Diabetol 31:187-92
Santamaria, P; Barbosa, J J; Lindstrom, A L et al. (1994) HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type I diabetic patients. J Clin Endocrinol Metab 78:878-83
Rich, S S; French, L R; Sprafka, J M et al. (1993) HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study. Diabetologia 36:234-8
French, L R; Goetz, F C; Martinez, A M et al. (1992) Association between stimulated plasma C-peptide and age: the Wadena City Health Study. J Am Geriatr Soc 40:309-15
Sprafka, J M; Xue, S; Bushhouse, S A et al. (1992) Cardiovascular disease risk factors and glucose tolerance. The Wadena City Health Study. Ann Epidemiol 2:647-56

Showing the most recent 10 out of 12 publications